Baxter International Inc. vs. Avita Medical, Inc. Common Stock
Baxter International Inc. and Avita Medical, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BAX | RCEL | |
|---|---|---|
| Market Cap | $11.79 billion | $347.00 million |
| Revenue (TTM) | $11.47 billion | $75.63 million |
| Net Income (TTM) | $-1,063,000,000 | $-43,082,000 |
BAX leads on 2 of 3 size & scale factors.
Valuation
| BAX | RCEL | |
|---|---|---|
| Price / Book | 1.91 | -12.46 |
| Price / Sales | 1.03 | 4.59 |
BAX and RCEL split the valuation factors evenly.
Profitability
| BAX | RCEL | |
|---|---|---|
| Net Margin | -9.27% | -56.96% |
| Return on Equity | -17.20% | 154.76% |
BAX and RCEL split the profitability factors evenly.
Dividend
| BAX | RCEL | |
|---|---|---|
| Dividend Yield | 0.18% | — |
BAX and RCEL split the dividend factors evenly.
Risk & Sentiment
| BAX | RCEL | |
|---|---|---|
| Short Interest | 1.03% | 0.34% |
RCEL leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, RCEL overview, RCEL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.